If the rate of transmission reaches the elusive herd immunity, the time-frame for the virus to evolve into evading vaccines grows significantly longer, even with a non-zero mutation rate.
Lastly, antibodies created via the mRNA vaccines have a broader binding affinity to different variants than those from natural immunity [1].
Again, the goal is to not eradicate, but to scale it down to the point where it is statistically not a threat.